Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.23.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Product Information [Line Items]        
Cash FDIC insurance $ 250,000   $ 250,000  
Cash SIPC insurance 500,000   500,000  
Patent and licensing legal and filing fees and costs $ 340,010 $ 358,389 $ 657,350 $ 673,626
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 10.00% 10.00% 10.00% 10.00%
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 27.30% 25.90% 27.10% 26.10%
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member] | Stock Options Granted to Directors and Corporate Officers [Member]        
Product Information [Line Items]        
Concentration risk percentage 22.50% 30.70% 23.00% 29.60%
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant One [Member]        
Product Information [Line Items]        
Concentration risk percentage 62.90% 29.70% 43.90% 44.60%
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Two [Member]        
Product Information [Line Items]        
Concentration risk percentage 12.40% 18.20% 17.10% 16.50%
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Three [Member]        
Product Information [Line Items]        
Concentration risk percentage   17.40% 11.20%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Four [Member]        
Product Information [Line Items]        
Concentration risk percentage   12.60%    
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor And Consultant Five [Member]        
Product Information [Line Items]        
Concentration risk percentage   10.20%